A recent study demonstrated mRNA-encoded STING adjuvant enhanced the efficacy of HPV E6/E7 vaccination in suppressing murine HPV+ TC-1 tumor growth, as evidenced by the reduced tumor volume and prolonged survival (58). The gene discussed is STING1; the disease is neoplasm.